Location History:
- Bry-sur-Marne, FR (1999 - 2006)
- Le Perreux, FR (2009)
Company Filing History:
4 out of 377 
1 out of 247 
1 out of 5,089 
Years Active: 1999-2009
Title: Patricia Lacroix: Innovator in Antibiotic Biosynthesis
Introduction
Patricia Lacroix is a prominent inventor based in Bry-sur-Marne, France. She has made significant contributions to the field of antibiotic biosynthesis, holding a total of 7 patents. Her work focuses on the isolation and identification of novel genes involved in the production of important antibiotics.
Latest Patents
One of her latest patents is titled "Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof." This invention relates to the discovery of new genes in the biosynthetic pathway for spiramycins, as well as the polypeptides that play a role in this process. The patent outlines methods for producing these polypeptides and discusses the use of these genes to enhance the production and purity of spiramycin. Additionally, it describes a microorganism that produces spiramycin I while not producing spiramycin II and III, along with the potential for creating mutants that could lead to new antibiotics. Another significant patent is focused on "Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use," which details methods for preparing pristinamycin IIA or IIB.
Career Highlights
Throughout her career, Patricia has worked with notable companies, including Aventis Pharma S.A. Her innovative research has positioned her as a key figure in the development of new antibiotic therapies.
Collaborations
Patricia has collaborated with esteemed colleagues such as Veronique Blanc and Francis Blanche, contributing to the advancement of her research and the field of antibiotic biosynthesis.
Conclusion
Patricia Lacroix's work in antibiotic biosynthesis has led to significant advancements in the field, with her patents paving the way for new therapeutic options. Her contributions continue to impact the development of novel antibiotics and enhance our understanding of biosynthetic pathways.